Huntington's Disease Genetic Testing Market Forecast Report 2030

Kits for testing for Huntington’s disease are readily available, which results in easy access to genetic testing services. As a result, the globalHuntington’s disease genetic testing market, which generated $20.6 million in 2019, is expected to experience a steady 3.1% CAGR between 2020 and 2030, to reach $28.3 million in 2030. Developed countries’ initiatives to check discrimination in genetic testing, promoting clinical research, and offering access to information and support have made these tests easily available. However, the root cause of the Huntington’s disease genetic testing market growth is the rising prevalence of this neurodegenerative disease. The International Parkinson and Movement Disorder Society estimates the 2019 global HD prevalence at 2.7 per 100,000 people, with the U.K., the U.S., and Germany accounting for the highest individual incidence. The coronavirus pandemic is harming the Huntington’s disease genetic testing market, as the manufacturing and supply of test kits have slowed down due to plant shutdowns and other restrictions around the world. Moreover, the focus presently is on dealing with the infection, which is why testing services, except the really important ones, are not being offered by a majority of medical centers. Huntington’s Disease Genetic Testing Market Segmentation Analysis The male bifurcation will continue holding the larger share in the Huntington’s disease genetic testing market in the years to come, on the basis of patient gender. Compared to females, males, especially senior citizens and adults, display a higher case count, which is most apparent in places where HD’s prevalence is extremely high. In the coming years, the fastest growth in the Huntington’s disease genetic testing market, based on patient group, is projected to be witnessed by the aged category. The geriatric population is increasing with the rising life expectancy, which why the incidence of HD in this age group is set to increase sharply in the future. North America generates the highest revenue in the Huntington’s disease genetic testing market, and it would also grow the fastest during the next decade. The region not only displays the highest HD incidence on earth, but it is also home to numerous key industry players. Additionally, a large number of facilities in the continent offer HD genetic testing services, and the expenditure on healthcare is also high here. Driven by the increasing population of the elderly, number of research studies centered on genetic diseases, and presence of market players, the market will keep advancing in the region. Market Competition Heating Up with Increasing Strategic Activities 2 © Prescient & Strategic Intelligence Private Limited. All rights reserved

Competition in the Huntington’s disease genetic testing market is heating up, as the players are engaging in an array of strategic activities. Some of the most- significant such developments in the industry in recent times are: •CaGaT GmbH’s launch of the CeGaT Exome Xtra genetic diagnostic tool in February 2020 •Quest Diagnostics Inc.’s January 2020 acquisition of Blueprint Genetics Oy •January 2019 commercialization of the AmplideX Huntington (HTT) kit by Asuragen Inc. Download sample pages https://www.psmarketresearch.com/market-analysis/huntingtons- disease-genetic-testing-market/report-sample The most-prominent companies in the global Huntington’s disease genetic testing market are: 1-Quest Diagnostics Inc. 2- Laboratory Corporation of America Holdings 3- CooperGenomics Inc. 4- EGL Genetic Diagnostics LLC 5- CeGaT GmbH 6- Blueprint Genetics Oy 7- Variantyx Inc. 8- Centogene N.V. 9- Asuragen Inc. Market Size Breakdown by Segment By Patient Gender Male Female By Patient Group Adult Aged Adolescent Child By Region North America Europe Asia-Pacific (APAC) of this report: • • • • • • • • • 3 © Prescient & Strategic Intelligence Private Limited. All rights reserved

Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners. An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Ltd. Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 4 ©P&SIntelligence.Allrightsreserved 5 © Prescient & Strategic Intelligence Private Limited. All rights reserved

Huntington's Disease Genetic Testing Market Forecast Report 2030